A detailed history of Center Book Partners LP transactions in Insulet Corp stock. As of the latest transaction made, Center Book Partners LP holds 14,346 shares of PODD stock, worth $4.48 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
14,346
Previous 3,193 349.3%
Holding current value
$4.48 Million
Previous $838,000 437.83%
% of portfolio
0.27%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$238.57 - $327.47 $2.66 Million - $3.65 Million
11,153 Added 349.3%
14,346 $4.51 Million
Q1 2025

May 09, 2025

BUY
$237.06 - $288.29 $756,932 - $920,509
3,193 New
3,193 $838,000
Q2 2024

Aug 12, 2024

BUY
$161.02 - $206.98 $756,149 - $971,978
4,696 New
4,696 $947,000
Q4 2023

Feb 13, 2024

BUY
$127.77 - $221.42 $610,612 - $1.06 Million
4,779 Added 108.56%
9,181 $1.99 Million
Q3 2023

Nov 13, 2023

BUY
$154.67 - $290.89 $680,857 - $1.28 Million
4,402 New
4,402 $702,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $21.7B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.